Genotyping, antifungal susceptibility testing, and biofilm formation of Trichosporon spp. isolated from urine samples in a University Hospital in Bangkok, Thailand
- 16 September 2022
- journal article
- research article
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 69 (3) , 247-257
Abstract
The basidiomycetes yeast Trichosporon is widespread in the natural environment, but can cause disease, mainly in immunocompromised patients. However, there have been only few studies about this infection in Thailand. In this study, we characterized 53 Trichosporon spp. isolated from urine samples from patients admitted to a single hospital in Bangkok, Thailand over a one-year period from 2019 to 2020. The strains were identified using colony morphology, microscopy, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and nucleotide sequence analysis of intergenic spacer 1 (IGS1). Fifty-one isolates were Trichosporon asahii, and the remaining isolates were Trichosporon inkin and other Trichosporon species. Three genotypes of IGS1—1, 3, and 7 were observed among T. asahii. The sensitivity of the yeasts to the antifungal drugs amphotericin B, fluconazole, and voriconazole ranged from 0.25 to >16 μg ml−1, 0.5–8 μg ml−1, and 0.01–0.25 μg ml−1, respectively. We investigated biofilm formation by the isolates, and no biofilm production was found in one isolate, low biofilm production in forty-four isolates, and medium biofilm production in six isolates. T. inkin produced biofilms at low levels, and Trichosporon spp. produced biofilms at medium levels. This research increases our understanding of the molecular epidemiology of Trichosporon spp. isolated from one university hospital in Bangkok, Thailand, and reveals their genetic diversity, antifungal susceptibility profiles, and capacity for in vitro biofilm production.Keywords
This publication has 43 references indexed in Scilit:
- Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testingJournal of Medical Microbiology, 2012
- Current Knowledge of Trichosporon spp. and TrichosporonosisClinical Microbiology Reviews, 2011
- Genotyping and Antifungal Drug Susceptibility of the Pathogenic Yeast Trichosporon asahii Isolated from Thai PatientsMycopathologia, 2009
- Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility TestingJournal of Clinical Microbiology, 2009
- Fungemia in non-HIV-infected patients: a five-year reviewInternational Journal of Infectious Diseases, 2009
- Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1Diagnostic Microbiology and Infectious Disease, 2007
- Biofilm Formation by the Emerging Fungal Pathogen Trichosporon asahii : Development, Architecture, and Antifungal ResistanceAntimicrobial Agents and Chemotherapy, 2006
- Analysis of Trichosporon Isolates Obtained from the Houses of Patients with Summer-Type Hypersensitivity PneumonitisJournal of Clinical Microbiology, 2004
- Sequence Analysis of the Ribosomal DNA Intergenic Spacer 1 Regions of Trichosporon SpeciesJournal of Clinical Microbiology, 2002
- A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequencesJournal of Molecular Evolution, 1980